京都大学医学部附属病院　循環器内科
同門会 交通アクセス プライバシーポリシー お問い合わせ

発表論文（英文） – 2019年

2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年 2016年 2015年 2014年 2013年 2012年 2011年 2010年 2009年 2008年 2007年 2006年 2005年 2004年 2003年 2002年 2001年 2000年 1999年 1998年 1997年 1996年 研究業績TOP
  1. Kimura T. Can ultra-thin strut drug-eluting stents improve outcomes? Lancet. 2019 Mar 9;393(10175):961-962.
  2. Ono K, Wada H, Satoh-Asahara N, Inoue H, Uehara K, Funada J, Ogo A, Horie T, Fujita M, Shimatsu A, Hasegawa K, ABLE-MET Investigators. Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial. Am J Cardiovasc Drugs. 2019 Nov 13. doi: 10.1007/s40256-019-00381-1. [Epub ahead of print]
  3. Ozasa N, Kimura T. Oralβ-Blocker Therapy in Acute Myocardial Infarction. Circ J. 2019 Jan 25;83(2):281-282. doi: 10.1253/circj.CJ-18-1364. Epub 2019 Jan 12.
  4. Kato T, Okano M, Haruna Y, Inoko M. Association between abnormal myocardial scintigraphy findings and long-term outcomes for elderly patients 85 years or older: a retrospective cohort study. BMC Cardiovasc Disord. 2019 Nov 6;19(1):246. doi: 10.1186/s12872-019-1240-y.
  5. Kato T, Uemura Y, Naya M, Momose M, Matsumoto N, Suzuki E, Hida S, Nakajima T, Yamauchi T, Tamaki N. Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina. Sci Rep. 2019 May 27;9(1):7882. doi: 10.1038/s41598-019-44371-4.
  6. Shiomi H, Kozuma K, Morimoto T, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Takeji Y, Suwa S, Ito Y, Kobayashi M, Dai K, Nakao K, Tarutani Y, Taniguchi R, Nishikawa H, Yamamoto Y, Nakagawa Y, Ando K, Kobayashi K, Kawai K, Hibi K, Kimura T; RESET Investigators. 7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial. JACC Cardiovasc Interv. 2019 Apr 8;12(7):637-647. doi: 10.1016/j.jcin.2019.01.234.
  7. Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Bonaca MP, Ruff CT, Desai AS, Goto S, Johansson PA, Gause-Nilsson I, Johanson P, Langkilde AM, Raz I, Sabatine MS, Wiviott SD. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18.
  8. Kato ET, Sabatine MS, Wiviott SD. Response by Kato et al to Letter Regarding Article, “Effect of Dapaglif lozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus”. Circulation. 2019 Oct 29;140(18):e740-e741. doi: 10.1161/CIRCULATIONAHA.119.042848. Epub 2019 Oct 28.
  9. Watanabe H, Morimoto T, Shiomi H, Yoshikawa Y, Kato T, Saito N, Shizuta S, Ono K, Yamaji K, Ando K, Kaji S, Furukawa Y, Akao M, Ishikawa T, Tamura T, Yamamoto Y, Muramatsu T, Suwa S, Nakagawa Y, Kadota K, Takatsu Y, Nishikawa H, Hiasa Y, Hayashi Y, Miyazaki S, Kimura T. Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies. Cardiovasc Interv Ther. 2019 Jan;34(1):47-58. doi: 10.1007/s12928-018-0517-x. Epub 2018 Mar 5.
  10. Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145.
  11. Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial. Circulation. 2019 Dec 3;140(23):1957-1959. doi: 10.1161/CIRCULATIONAHA.119.043613. Epub 2019 Sep 27.
  12. Watanabe H, Kimura T. 1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention-Reply. JAMA. 2019 Nov 5;322(17):1715-1716. doi: 10.1001/jama.2019.14250.
  13. Tazaki J, Hasegawa K, Kimura T. Antithrombotic therapy for lower extremity artery disease: is more intense therapy required? Eur Heart J Cardiovasc Pharmacother. 2019 Sep 27. pii: pvz044. doi: 10.1093/ehjcvp/pvz044. [Epub ahead of print]
  14. Ide Y, Horie T, Saito N, Watanabe S, Otani C, Miyasaka Y, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Koyama S, Kimura M, Tsuji S, Rodriguez RR, Xu S, Yamasaki T, Watanabe T, Yamamoto M, Yanagita M, Kimura T, Kakizuka A, Ono K. Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction. JACC Basic Transl Sci. 2019 Oct 28;4(6):701-714. doi: 10.1016/j.jacbts.2019.06.001. eCollection 2019 Oct.
  15. Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fracassi F, Sugiyama T, Lee H, Crea F, Kimura T, Fujimoto JG, Fuster V, Jang IK. Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes. J Am Heart Assoc. 2019 Nov 5;8(21):e012322. doi: 10.1161/JAHA.119.012322. Epub 2019 Oct 23. PubMed PMID: 31640466; PubMed Central PMCID: PMC6898801.
  16. Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Minatoya K, Kimura T. A Risk Prediction Model in Asymptomatic Patients with Severe Aortic Stenosis: CURRENT-AS risk score. Eur Heart J Qual Care Clin Outcomes. 2019 Aug 6. pii: qcz044. doi: 10.1093/ehjqcco/qcz044. [Epub ahead of print]
  17. Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Izumi C, Nakatsuma K, Inoko M, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Mitsuoka H, Hirano Y, Sasa T, Nagao K, Inada T, Nishikawa R, Takeuchi Y, Matsuda S, Yamane K, Su K, Komasa A1, Ishii K19, Kato Y20, Takabayashi K21, Watanabe S1, Saito N1, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Decline in Left Ventricular Ejection Fraction During Follow-Up in Patients With Severe Aortic Stenosis. JACC Cardiovasc Interv. 2019 Dec 23;12(24):2499-2511. doi: 10.1016/j.jcin.2019.09.015.
  18. Matsumura-Nakano Y, Kawaji T, Shiomi H, Kawai-Miyake K, Kataoka M, Koizumi K, Matsuda A, Kitano K, Yoshida M, Watanabe H, Tazaki J, Kato T, Saito N, Shizuta S, Ono K, Togashi K, Morimoto T, Kimura T. Optimal Cutoff Value of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography for Predicting Hemodynamically Significant Coronary Artery Disease. Circ Cardiovasc Imaging. 2019 Aug;12(8):e008905. doi: 10.1161/CIRCIMAGING.119.008905. Epub 2019 Aug 1.
  19. Matsumura-Nakano Y, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Yamaji K, Shizuta S, Sakata R, Hanyu M, Shimamoto M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease. Circ J. 2019 Sep 25;83(10):2061-2069. doi: 10.1253/circj.CJ-19-0440. Epub 2019 Aug 22.
  20. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; for the KCHF Study Investigators. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure. JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.
  21. Yamashita Y, Murata K, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Nawada R, Onodera T, Kimura T; COMMAND VTE Registry Investigators. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry. Thromb Res. 2019 Dec;184:50-57. doi: 10.1016/j.thromres.2019.10.029. Epub 2019 Nov 1.
  22. Yamashita Y, Yoshikawa Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry. Int J Cardiol. 2019 Oct 1;292:198-204. doi: 10.1016/j.ijcard.2019.06.032. Epub 2019 Jun 13.
  23. Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators. Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry. J Thromb Thrombolysis. 2019 Apr;47(3):444-453. doi: 10.1007/s11239-018-1791-2.
  24. Yoshikawa Y, Kimura T. Percutaneous coronary intervention in stable coronary artery disease: still in equipoise? Eur Heart J. 2019 Jan 7;40(2):187-189. doi: 10.1093/eurheartj/ehy859.
  25. Yoshikawa Y, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen P-M, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T, COMMAND VTE Registry Investigators. Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism – From the COMMAND VTE Registry. Circ J. 2019 Jun 25;83(7):1581-1589. doi: 10.1253/circj.CJ-19-0229. Epub 2019 May 28.
  26. Yoshikawa Y, Shiomi H, Kuwahara K, Sowa N, Yaku H, Yamashita Y, Tazaki J, Imai M, Kato T, Saito N, Shizuta S, Ono K, Kimura T. Utility of copeptin for predicting long-term clinical outcomes in patients with heart failure. J Cardiol. 2019 May;73(5):379-385. doi: 10.1016/j.jjcc.2018.11.008. Epub 2018 Dec 24.
  27. Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry. Thromb Res. 2019 May;177:1-9. doi: 10.1016/j.thromres.2019.02.029. Epub 2019 Feb 25.
  28. Tsuji S, Koyama S, Taniguchi R, Fujiwara T, Fujiwara H, Sato Y. Association of Serum Amino Acid Concentration With Loss of Skeletal Muscle Mass After 1 Year in Cardiac Rehabilitation Center Patients. Circ Rep. 2019; 1: 456-461. doi:10.1253/circrep.CR-19-0053.
  29. Su K, Kato T, Toyofuku M, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Motohashi Y, Watanabe H, Kitai T, Taniguchi R, Iguchi M, Kato M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Jinnai T, Kawato M, Sato Y, Kuwahara K, Tamura T, Kimura T, KCHF Registry Investigators. Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure. Circ Rep. 2019; 1: 517–524. doi:10.1253/circrep.CR-19-0054.
  30. Seko Y, Kato T, Shiba M, Morita Y, Yamaji Y, Haruna Y, Nakane E, Haruna T, Inoko M. Isolated Tricuspid Regurgitation and Long-Term Outcome in Patients With Preserved Ejection Fraction. Circ Rep. 2019; 1: 617–622. doi:10.1253/circrep.CR-19-0112.
  31. Seko Y, Kato T, Shiba M, Morita Y, Yamaji Y, Haruna Y, Nakane E, Hayashi H, Haruna T, Inoko M. Association of the low e’and high E/e’with long-term outcomes in patients with normal ejection fraction. BMJ Open. 2019 Nov 21;9(11):e032663. doi: 10.1136/bmjopen-2019-032663.
  32. Seko Y, Kato T, Shiba M, Morita Y, Yamaji Y, Haruna Y, Nakane E, Haruna T, Inoko M. Staging Cardiac Damage in Patients With Hypertension. Hypertension. 2019 Dec;74(6):1357-1365. doi: 10.1161/HYPERTENSIONAHA.119.13797. Epub 2019 Nov 4.
  33. Seko Y, Kato T, Morita Y, Yamaji Y, Haruna Y, Nakane E, Haruna T, Inoko M. Association with left atrial volume index and long-term prognosis in patients without systolic dysfunction nor atrial fibrillation: an observational study. Heart Vessels. 2020 Feb;35(2):223-231. doi: 10.1007/s00380-019-01469-z. Epub 2019 Jul 11.
  34. Seko Y, Kato T, Morita Y, Yamaji Y, Haruna Y, Izumi T, MiyamotoS, Nakane E, Hayashi H, Haruna T, Inoko M. Age- and body size- adjusted left ventricular end-diastolic dimension in a Japanese hospital-based population. Circ J. 2019 Feb 25;83(3):604-613. doi: 10.1253/circj.CJ-18-1095. Epub 2019 Jan 30.
  35. Takeji Y, Taniguchi T, Morimoto T, Saito N, Ando K, Shirai S, Sakaguchi G, Arai Y, Fuku Y, Kawase Y, Komiya T, Ehara N, Kitai T, Koyama T, Watanabe S, Watanabe H, Shiomi H, Minamino-Muta E, Matsuda S, Yaku H, Yoshikawa Y, Yamazaki K, Kawatou M, Sakamoto K, Tamura T, Miyake M, Sakaguchi H, Murata K, Nakai M, Kanamori N, Izumi C, Mitsuoka H, Kato M, Hirano Y, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Tamura T, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Higashitani N, Kato Y, Inuzuka Y, Morikami Y, Minatoya K, Kimura T; on befalf of the CURRENT AS Registry Investigators and K-TAVI Registry Investigators. Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice. PLoS One. 2019 Sep 26;14(9):e0222979. doi: 10.1371/journal. pone.0222979. eCollection 2019.
  36. Shiba M, Kato T, IzumiT, Miyamoto S, Nakane E, Haruna T, Inoko M. Risk of myocardial infarction in patients with psoriasis: A cross-sectional patient-population study in a Japanese hospital. J Cardiol. 2019 Apr;73(4):276-279. doi: 10.1016/j.jjcc.2018.10.008. Epub 2018 Dec 21.
  37. Yamamoto K, Shiomi H, Morimoto T, Natsuaki M, Takeji Y, Watanabe H, Yoshikawa Y, Matsumura-Nakano Y, Shizuta S, Tanabe K, Ando K, Kadota K, Morino Y, Kozuma K, Nakagawa Y, Kimura T. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention. Am J Cardiol. 2020 Feb 1;125(3):399-408. doi: 10.1016/j.amjcard.2019.10.049. Epub 2019 Nov 7.
  38. Abe M, Morimoto T, Morino Y, Tanaka H, Akao M, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Yumoto K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Hinohara T, Kadota K, Kimura T; J-CTO Registry Investigators. Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO Registry). Catheter Cardiovasc Interv. 2019 May 1;93(6):1025-1032. doi: 10.1002/ccd.28104. Epub 2019 Feb 5.
  39. Ako J, Okumura K, Nakao K, Kozuma K, Morino Y, Okazaki K, Fukaya T, Kimura T; RE-DUAL PCI Trial Investigators. Dual Anti-Thrombotic Therapy With Dabigatran After Percutaneous Coronary Intervention in Atrial Fibrillation – Japanese and East-Asian Subgroup Analysis of the RE-DUAL PCI Trial. Circ J. 2019 Jan 25;83(2):327-333. doi: 10.1253/circj.CJ-18-0874. Epub 2019 Jan 11.
  40. Al-Huseini I1, Harada M, Nishi K, Nguyen-Tien D, Kimura T, Ashida N. Improvement of insulin signalling rescues inflammatory cardiac dysfunction. Sci Rep. 2019 Oct 15;9(1):14801. doi: 10.1038/s41598-019-51304-8.
  41. An J, Naruse TK, Hinohara K, Soejima Y, Sawabe M, Nakagawa Y, Kuwahara K4, Kimura A. MRTF-A regulates proliferation and survival properties of pro-atherogenic macrophages. J Mol Cell Cardiol. 2019 Aug;133:26-35. doi: 10.1016/j.yjmcc.2019.05.015. Epub 2019 May 22.
  42. Azuma N, Takahara M, Kodama A, Soga Y, Terashi H, Tazaki J, Yamaoka T, Koya A, Iida O. Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia. Circ Cardiovasc Interv. 2019 Dec;12(12):e008015. doi: 10.1161/CIRCINTERVENTIONS.119.008015. Epub 2019 Nov 27.
  43. Baber U, Stefanini GG, Giustino G, Stone GW, Leon MB, Sartori S, Aquino M, Steg PG, Windecker S, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari DE, von Birgelen C, Dangas GD, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. Circ Cardiovasc Interv. 2019 Jul;12(7):e007734. doi: 10.1161/CIRCINTERVENTIONS.118.007734. Epub 2019 Jul 10.
  44. Chonabayashi K, Yoshida Y, Kitawaki T, Nannya Y, Nakamura M, Oshima S, Hishizawa M, Yamashita K, Ogawa S, Takaori-Kondo A. Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis. Ann Hematol. 2019 Dec;98(12):2841-2843. doi: 10.1007/s00277-019-03838-0. Epub 2019 Nov 14.
  45. Elbadry MI, Mizumaki H, Hosokawa K, Espinoza JL, Nakagawa N, Chonabayashi K, Yoshida Y, Katagiri T, Hosomichi K, Zaimoku Y, Imi T, Nguyen MAT, Fujii Y, Tajima A, Ogawa S, Takenaka K, Akashi K, Nakao S. Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia. Haematologica. 2019 Oct;104(10):e447-e450. doi: 10.3324/haematol.2018.210856. Epub 2019 Mar 19.
  46. Fujita T, Takeda T, Hano Y, Takashima N, Yamaji M, Sakaguchi T, Maeda K, Mabuchi H, Murakami T, Morimoto T, Kimura T. Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study. Coron Artery Dis. 2019 Sep;30(6):432-439. doi: 10.1097/MCA.0000000000000731.
  47. Fuku Y, Kadota K, Toyofuku M, Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators. Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions. Am J Cardiol. 2019 Jun 1;123(11):1796-1805. doi: 10.1016/j.amjcard.2019.03.002. Epub 2019 Mar 9.
  48. Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H, Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H; Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J. 2019 Mar 25;83(4):842-945. doi: 10.1253/circj.CJ-66-0158. Epub 2019 Mar 9.
  49. Gotoh D, Torimoto K, Iwasaki H, Iwamoto T, Morizawa Y, Hori S, Miyake M, Tanaka N, Hirayama A, Nishi E, Fujimoto K. Tadalafil, a phosphodiesterase type 5 inhibitor, restores urethra and detrusor function in the initial phase of diabetes in rats. Low Urin Tract Symptoms. 2019 Sep;11(4):241-247. doi: 10.1111/luts.12272. Epub 2019 Jun 17.
  50. Ihdayhid AR, Norgaard BL, Gaur S, Leipsic J, Nerlekar N, Osawa K, Miyoshi T, Jensen JM, Kimura T, Shiomi H, Erglis A, Jegere S, Oldroyd KG, Botker HE, Seneviratne SK, Achenbach S, Ko BS. Prognostic Value and Risk Continuum of Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography. Radiology. 2019 Aug;292(2):343-351. doi: 10.1148/radiol.2019182264. Epub 2019 Jun 11.
  51. Ikuta K, Fukuda A, Ogawa S, Masuo K, Goto N, Hiramatsu Y, Tsuda M, Kimura Y, Matsumoto Y, Kimura Y, Maruno T, Kanda K, Nishi K, Takaori K, Uemoto S, Takaishi S, Chiba T, Nishi E and Seno H. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Gut. 2019 May;68(5):882-892. doi: 10.1136/gutjnl-2017-315425. Epub 2018 May 24.
  52. Ishii M, Taniguchi T, Morimoto T, Ogawa H, Masunaga N, Abe M, Yoshikawa Y, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Akao M, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Reasons for Choosing Conservative Management in Symptomatic Patients With Severe Aortic Stenosis – Observations From the CURRENT AS Registry. Circ J. 2019 Aug 23;83(9):1944-1953. doi: 10.1253/circj.CJ- 19-0247. Epub 2019 Jul 17.
  53. Kanamori N, Taniguchi T, Morimoto T, Watanabe H, Shiomi H, Ando K, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Aoyama T, Kimura T; CURRENT AS Registry Investigators. Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection Fraction. J Am Heart Assoc. 2019 Feb 5;8(3):e010198. doi: 10.1161/JAHA.118.010198.
  54. Kawaji T, Numamoto H, Yamagami S, Mabuchi R, Kitamura T, Enoki N, Koizumi K, Kanao S, Kato M, Yokomatsu T, Shizuta S, Miki S, Ono K, Togashi K, Kimura T. Real-time surveillance of left atrial appendage thrombus during contrast computed tomography imaging for catheter ablation: THe Reliability of cOMputed tomography Beyond UltraSound in THROMBUS detection (THROMBUS) study. J Thromb Thrombolysis. 2019 Jan;47(1):42-50.
  55. Kawaji T, Shizuta S, Yamagami S, Aizawa T, Komasa A, Yoshizawa T, Kato M, Yokomatsu T, Miki S, Ono K, Kimura T. Early choice for catheter ablation reduced readmission in management of atrial fibrillation: Impact of diagnosis-to-ablation time. Int J Cardiol. 2019 Mar 20. pii: S0167-5273(18)37345-5.
  56. Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita J, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Physiol Rev. 2019 Jan 1;99(1):79-114. doi: 10.1152/physrev.00039.2017.
  57. Kayawake H, Aoyama A, Kinoshita H, Yoneda T, Baba S, Teramoto Y, Miyagawa-Hayashino A, Yamazaki K, Motoyama H, Hamaji M, Nakajima D, Chen-Yoshikawa TF, Date H. Diameter of the dilated main pulmonary artery in patients with pulmonary hypertension decreeses after lung transplantation. Surg Today. 2020 Mar;50(3):275-283. doi: 10.1007/s00595-019-01887-6. Epub 2019 Oct 8.
  58. Kereiakes DJ, Windecker S, Jobe RL, Mehta SR, Sarembock IJ, Feldman RL, Stein B, Dubois C, Grady T, Saito S, Kimura T, Underwood P, Allocco DJ, Meredith IT. Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents. Circ Cardiovasc Interv. 2019 Sep;12(9):e008152. doi: 10.1161/CIRCINTERVENTIONS.119.008152. Epub 2019 Aug 27.
  59. Kim K, Yamashita Y, Morimoto T, Kitai T, Yamane T, Ehara N, Kinoshita M, Kaji S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Furukawa Y, Kimura T; COMMAND VTE Registry Investigators. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry. Thromb Haemost. 2019 Sep;119(9):1498-1507. doi: 10.1055/s-0039-1692425. Epub 2019 Jun 23.
  60. Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T; Japanese Circulation Society Joint Working Group. JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J. 2019 Apr 25;83(5):1085-1196.
  61. Kimura Y, Kato T, Miyata H, Sasaki I, Minamino-Muta E, Nagasawa Y, Numao S, Nagano T, Higuchi T, Inoko M. Left Ventricular Diastolic Function during the Normal Peripartum Period. Circ J. 2019 Oct 25;83(11):2265-2270. doi: 10.1253/circj.CJ-19-0501. Epub 2019 Sep 22.
  62. Kimura Y, Kato T, Miyata H, Sasaki I, Minamino-Muta E, Nagasawa Y, Numao S, Nagano T, Higuchi T, Inoko M. Factors Associated with Increased Levels of Brain Natriuretic Peptide and Cardiac Troponin I during the Peripartum Period. PLoS One. 2019 Feb 7;14(2):e0211982. doi: 10.1371/journal.pone.0211982. eCollection 2019.
  63. Koyama S, Horie T, Nishino T, Baba O, Sowa N, Miyasaka Y, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Ide Y, Kimura M, Tsuji S, Rodriguez RR, Xu S, Yamasaki T, Otani C, Watanabe T, Nakamura T, Hasegawa K, Kimura T, Ono K. Identification of Differential Roles of MicroRNA-33a and -33b During Atherosclerosis Progression With Genetically Modified Mice. J Am Heart Assoc. 2019 Jul 2;8(13):e012609. doi: 10.1161/JAHA.119.012609. Epub 2019 Jun 27.
  64. Kozuma K, Shinozaki T, Kozuma K, Kashiwabara K, Oba K, Aoki J, Awata M, Nanasato M, Shiode N, Tanabe K, Yamaguchi J, Kimura T, Matsuyama Y. Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent. Int Heart J. 2019 Sep 27;60(5):1050-1060. doi: 10.1536/ihj.18-717. Epub 2019 Sep 4.
  65. Kuramitsu S, Ohya M, Shinozaki T, Otake H, Horie K, Kawamoto H, Yamanaka F, Natsuaki M, Shiomi H, Nakazawa G, Ando K, Kadota K, Saito S, Kimura T. Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis. Circ Cardiovasc Interv. 2019 Jun;12(6):e007822. doi: 10.1161/CIRCINTERVENTIONS.119.007822. Epub 2019 Jun 10.
  66. Kushiyama A, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Age-Related Differences in the Effects of Initial Aortic Valve Replacement vs. Conservative Strategy on Long-Term Outcomes in Asymptomatic Patients With Severe Aortic Stenosis. Circ J. 2020 Jan 24;84(2):252-261. doi: 10.1253/circj. CJ-19-0431. Epub 2019 Dec 25.
  67. Lip GYH, Bhatt DL, Hohnloser SH, Kimura T, Miede C, Nordaby M, Oldgren J, Steg PG, Ten Berg JM, Cannon CP. Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range. J Am Coll Cardiol. 2019 Nov 12;74(19):2431-2433. doi: 10.1016/j.jacc.2019.09.009.
  68. Lip GYH, Mauri L, Montalescot G, Ozkor M, Vardas P, Steg PG, Bhatt DL, Hohnloser SH, Miede C, Nordaby M, Brueckmann M, Kreuzer J, Kimura T, Oldgren J, Ten Berg JM, Cannon CP. Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. Am Heart J. 2019 Mar 1;212:13-22.
  69. Masuta K, Funatsuki K, Inoue Y, Masud I, Nishikimi T, Nakagawa Y, Horii K, Nishi H. Irgarashi M, Ota N. A Mixture of Glycosylated proBNP and BNP-32 Is a Suitable Calibrator for BNP Immunoassays.Open Journal of Clinical Diagnostics, 2019, 9, 51-63. DOI: 10.4236/ojcd.2019.92004 Jun. 29, 2019.
  70. Maeng M, Steg PG, Bhatt DL, Hohnloser SH, Nordaby M, Miede C, Kimura T, Lip GYH, Oldgren J, Ten Berg JM, Cannon CP; RE-DUAL PCI Steering Committee and Investigators. Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. JACC Cardiovasc Interv. 2019 Dec 9;12(23):2346-2355. doi: 10.1016/j.jcin.2019.07.059.
  71. Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, Murphy SA, Heerspink HJL, Zelniker TA, Dwyer JP, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Kato ET, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS, Raz I. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial. Lancet Diabetes Endocrinol. 2019 Aug;7(8):606-617. doi: 10.1016/S2213-8587(19)30180-9. Epub 2019 Jun 10.
  72. Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Anemia in Patients with Severe Aortic Stenosis. Sci Rep. 2019 Feb 13;9(1):1924. doi: 10.1038/s41598-018-36066-z. PMID: 30760807; PMCID: PMC6374463.
  73. Nagao K, Watanabe H, Morimoto T, Inada T, Hayashi F, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Natsuaki M, Kozuma K, Tanabe K, Morino Y, Shiomi H, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort‐2, RESET, and NEXT Investigators. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions. J Am Heart Assoc. 2019 Nov 19;8(22):e013703. doi: 10.1161/JAHA.119.013703. Epub 2019 Nov 8. PMID: 31701786; PMCID: PMC6915278.
  74. Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K. MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. Clin Sci (Lond). 2019 Feb 22;133(4):583-595. doi: 10.1042/CS20180980. Print 2019 Feb 28.
  75. Natsuaki M, Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, Kato T, Ando K, Nakagawa Y, Furukawa Y, Tada T, Nagao K, Kadota K, Toyofuku M, Kimura T. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 Nov;12(11):e008307. doi: 10.1161/CIRCINTERVENTIONS.119.008307. Epub 2019 Nov 11.
  76. Natsuaki M, Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG registry cohort‐2, RESET and NEXT trial investigators. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke. J Am Heart Assoc. 2019 Nov 19;8(22):e013356. doi: 10.1161/JAHA.119.013356. Epub 2019 Nov 8.
  77. Nishikimi T, Nakagawa Y. Dose impaired processing of pro-B-type (or brain) natriuretic peptide cause decreased plasma BNP levels in obese heart failure patients? Ann Transl Med. 2019 Sep; 7(Suppl 6): S221. doi: 10.21037/atm.2019.08.56.
  78. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry. J Thromb Thrombolysis. 2019 Nov;48(4):587-595. doi: 10.1007/s11239-019-01913-x.
  79. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Group. Validation of the VTE-BLEED score’s long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry. J Thromb Haemost. 2020 Mar;18(3):624-632. doi: 10.1111/jth.14691. Epub 2019 Dec 27.
  80. Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators. Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset – From the COMMAND VTE Registry. Circ J. 2019 May 24;83(6):1377-1384. doi: 10.1253/circj.CJ-18-1314. Epub 2019 Mar 30.
  81. Ohno M, Chen PM, Kimura T and Nishi E. Response to Letter of Stephenson et al.: Nardilysin: a potential biomarker for the early diagnosis of acute coronary syndrome. Int J Cardiol. 2019 Feb 15;277:249. doi: 10.1016/j.ijcard.2018.10.022.
  82. Oldgren J, Steg PG, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Brueckmann M, Kleine E, Ten Berg JM, Bhatt DL, Cannon CP. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. Eur Heart J. 2019 May 14;40(19):1553-1562. doi: 10.1093/eurheartj/ehz059.
  83. Oshita K, Kozasa Y, Nakagawa Y, Kuwabara Y, Kuwahara K, Nakagawa T, Nakashima N, Hiraki T, Takano M. Overexpression of the HCN2 channel increases the arrhythmogenicity induced by hypokalemia. J Physiol Sci. 2019 Jul;69(4):653-660. doi: 10.1007/s12576-019-00684-7. Epub 2019 May 13.
  84. Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Tamura T, Nakagawa Y, Kimura K, on behalf of the COMMAND VTE Registry Investigators. Cancer-Associated Venous Thromboembolism in the Real World -From the COMMAND VTE Registry–. Circ J. 2019 Oct 25;83(11):2271-2281. doi: 10.1253/circj.CJ-19-0515. Epub 2019 Sep 20.
  85. Shimizu W, Makimoto H, Yamagata K, Kamakura T, Wada M, Miyamoto K, Inoue-Yamada Y, Okamura H, Ishibashi K, Noda T, Nagase S, Miyazaki A, Sakaguchi H, Shiraishi I, Makiyama T, Ohno S, Itoh H, Watanabe H, Hayashi K, Yamagishi M, Morita H, Yoshinaga M, Aizawa Y, Kusano K, Miyamoto Y, Kamakura S, Yasuda S, Ogawa H, Tanaka T, Sumitomo N, Hagiwara N, Fukuda K, Ogawa S, Aizawa Y, Makita N, Ohe T, Horie M, Aiba T. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients. JAMA Cardiol. 2019 Feb 13. doi: 10.1001/jamacardio.2018.4925. PMID: 30758498.
  86. Stone GW, Kimura T, Gao R, Kereiakes DJ, Ellis SG, Onuma Y, Chevalier B, Simonton C, Dressler O, Crowley A, Ali ZA, Serruys PW. Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study. JAMA Cardiol. 2019 Sep 27. doi: 10.1001/jamacardio.2019.4101. [Epub ahead of print]
  87. Suematsu Y, Zhang B, Kuwano T, Sako H, Ogawa M, Yonemoto N, Nonogi H, Kimura T, Nagao K, Yasunaga S, Saku K, Miura SI; Japanese Circulation Society with Resuscitation Science Study (JCS-ReSS) Group. Citizen bystander-patient relationship and 1-month outcomes after out-of-hospital cardiac arrest of cardiac origin from the All-Japan Utstein Registry: a prospective, nationwide, population-based, observational study. BMJ Open. 2019 Jul 26;9(7):e024715. doi: 10.1136/bmjopen-2018-024715.
  88. Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Tricoci P, Xavier D, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial. J Am Coll Cardiol. 2019 Feb 5;73(4):387-396. doi: 10.1016/j.jacc.2018.10.039. Epub 2018 Nov 11.
  89. Takaki T, Inagaki A, Chonabayashi K, Inoue K, Miki K, Ohno S, Makiyama T, Horie M, Yoshida Y. Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patient. Stem Cells Int. 2019 Mar 6;2019:7532657. doi: 10.1155/2019/7532657. eCollection 2019.
  90. Takashio S, Takahama H, Nishikimi T, Hyashi T, Nagai-Okatani C, Matuso A, Nakagawa Y, Amano M, Hamatani Y, Okada A, Amaki M, Hasegawa T, KanzakiH, Yaduda S, Kangawa K, Anzai T, Minamino N, Izumi C. Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: compareson With B-type natriureteic peptide and other natriuretic peptide forms. Open Heart. 2019 Jul 29;6(2):e001072. doi: 10.1136/openhrt-2019-001072. eCollection 2019.
  91. Takayama K, Ohno S, Ding WG, Ashihara T, Fukumoto D, Wada Y, Makiyama T, Kise H, Hoshiai M, Matsuura H, Horie M. A de novo gain-of-function KCND3 mutation in early repolarization syndrome. Heart Rhythm. 2019 Jun 4. pii: S1547-5271(19)30543-0. doi: 10.1016/j.hrthm.2019.05.033. [Epub ahead of print] PMID: 31173922.
  92. Ten Berg JM, Steg PG, Bhatt DL, Hohnloser SH, de Veer A, Nordaby M, Miede C, Kimura T, Lip GYH, Oldgren J, Cannon CP; RE-DUAL PCI Steering Committee and Investigators. Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). Am J Cardiol. 2020 Mar 1;125(5):735-743. doi: 10.1016/j.amjcard.2019.11.029. Epub 2019 Dec 9.
  93. Toyota T, Morimoto T, Yamashita Y, Shiomi H, Kato T, Makiyama T, Nakagawa Y, Saito N, Shizuta S, Ono K, Kimura T. More- Versus Less-Intensive Lipid-Lowering Therapy. Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005460. doi: 10.1161/CIRCOUTCOMES.118.005460. Epub 2019 Aug 15.
  94. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, Kitakaze M, Kinugawa K, Kihara Y, Goto Y, Komuro I, Saiki Y, Saito Y, Sakata Y, Sato N, Sawa Y, Shiose A, Shimizu W, Shimokawa H, Seino Y, Node K, Higo T, Hirayama A, Makaya M, Masuyama T, Murohara T, Momomura SI, Yano M, Yamazaki K, Yamamoto K, Yoshikawa T, Yoshimura M, Akiyama M, Anzai T, Ishihara S, Inomata T, Imamura T, Iwasaki YK, Ohtani T, Onishi K, Kasai T, Kato M, Kawai M, Kinugasa Y, Kinugawa S, Kuratani T, Kobayashi S, Sakata Y, Tanaka A, Toda K, Noda T, Nochioka K, Hatano M, Hidaka T, Fujino T, Makita S, Yamaguchi O, Ikeda U, Kimura T, Kohsaka S, Kosuge M, Yamagishi M, Yamashina A; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure – Digest Version. Circ J. 2019 Sep 25;83(10):2084-2184. doi: 10.1253/circj.CJ-19-0342. Epub 2019 Sep 10.
  95. Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T,Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention. Circulation. 2019 Jul 16;140(3):240-261. doi: 10.1161/CIRCULATIONAHA.119.040167. Epub 2019 May 22.
  96. Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.
  97. Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R. ST-segment elevation myocardial infarction. Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3.
  98. Watanabe Hiroki, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Tazaki J, Watanabe H, Natsuaki M, Minatoya K, Hanyu M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2). Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420. [Epub ahead of print]
  99. Watanabe Y, Sakakura K, Fujita H, Ohya M, Horie K, Yamanaka F, Nakazawa G, Otake H, Shiomi H, Natsuaki M, Ando K, Kadota K, Saito S, Kimura T, Kuramitsu S; REAL-ST Registry Investigators. Comparison of Clinical Characteristics of Stent Thrombosis Between the Right Coronary Artery and the Left Coronary Artery – A Subanalysis of the REAL-ST Registry. Circ J. 2020 Jan 24;84(2):169-177. doi: 10.1253/circj.CJ-19-0885. Epub 2019 Dec 28.
  100. Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot JS, Knollmann BC, Schwartz PJ. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circ Res. 2019 Aug 30;125(6):653-658. doi: 10.1161/CIRCRESAHA.119.315209. Epub 2019 Aug 29.
  101. Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Cell Stem Cell. 2019 Apr 4;24(4):566-578.e7. doi: 10.1016/j.stem.2019.02.005. Epub 2019 Mar 7.
  102. Wu Q, Hayashi H, Hira D, Sonoda K, Ueshima S, Ohno S, Makiyama T, Terada T, Katsura T, Miura K, Horie M. Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: Insights into syncope after drinking alcohol. J Arrhythm. 2019 Aug 19;35(5):752-759. doi: 10.1002/joa3.12227. eCollection 2019 Oct. PMID: 31624517.
  103. Yamada N, Asano Y, Fujita M, Yamazaki S, Inanobe A, Matsuura N, Kobayashi H, Ohno S, Ebana Y, Tsukamoto O, Ishino S, Takuwa A, Kioka H, Yamashita T, Hashimoto N, Zankov DP, Shimizu A, Asakura M, Asanuma H, Kato H, Nishida Y, Miyashita Y, Shinomiya H, Naiki N, Hayashi K, Makiyama T, Ogita H, Miura K, Ueshima H, Komuro I, Yamagishi M, Horie M, Kawakami K, Furukawa T, Koizumi A, Kurachi Y, Sakata Y, Minamino T, Kitakaze M, Takashima S. Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation. Circulation. 2019 Feb 15. doi: 10.1161/CIRCULATIONAHA.118.036761. PMID: 30764634.
  104. Yoh T, Hatano E, Kasai Y, Fuji H, Nishi K, Toriguchi K, Sueoka H, Ohno M, Seo S, Iwaisako K, Taura K, Yamaguchi R, Kurokawa M, Fujimoto J, Kimura T, Uemoto S, and Nishi E. Serum nardilysin, a surrogate marker for epithelial-mesenchymal transition, predicts prognosis of intrahepatic cholangiocarcinoma after surgical resection. Clin Cancer Res. 2019 Jan 15;25(2):619-628. doi: 10.1158/1078-0432.CCR-18-0124. Epub 2018 Oct 23.
  105. Yoshinaga D, Baba S, Makiyama T, Shibata H, Hirata T, Akagi K, Matsuda K, Kohjitani H, Wuriyanghai Y, Umeda K, Yamamoto Y, Conklin BR, Horie M, Takita J, Heike T. Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells. Stem Cell Reports. 2019 Aug 13;13(2):394-404. doi: 10.1016/j.stemcr.2019.06.007. Epub 2019 Aug 1. PMID: 31378668.
  106. Zelniker T, Wiviott S, Raz I, Im K, Im KA, Goodrich E, Furtado RHM, Bonaca M, Mosenzon O, Kato ET, Cahn A, Bhatt D, Leiter L, McGuire D, Wilding J, Sabatine M. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. Circulation. 2019 Apr 23;139(17):2022-2031. doi: 10.1161/CIRCULATIONAHA.118.038868.
Scroll